naftopidil has been researched along with Nycturia in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adachi, T; Kuratsukuri, K; Nakamura, T; Nakatani, T; Ohmachi, T; Tamada, S; Tanaka, T; Yamaguchi, T; Yamamoto, S; Yoshimura, R | 1 |
| Oh-oka, H | 2 |
| Aoki, Y; Namiki, M; Okuyama, A; Takao, T; Tsujimura, A; Yokoyama, O | 1 |
| Iwaki, H; Konishi, T; Narita, M; Okada, Y; Sakano, Y; Soga, H | 1 |
| Hashimoto, Y; Hatakeyama, S; Kamimura, N; Kawaguchi, T; Koie, T; Kudo, S; Ohyama, C; Takahashi, S; Yoneyama, T; Yoshikawa, K | 1 |
| Hamano, S; Murakami, S; Nakatsu, H; Naoi, M; Sekiyama, K; Suzuki, N; Tanaka, M | 1 |
3 trial(s) available for naftopidil and Nycturia
| Article | Year |
|---|---|
Efficacy of naftopidil for nocturia in male patients with lower urinary tract symptoms: comparison of morning and evening dosing.
Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Humans; Male; Middle Aged; Multivariate Analysis; Naphthalenes; Nocturia; Piperazines; Prostatic Hyperplasia; Quality of Life; Time Factors; Treatment Outcome; Urodynamics | 2015 |
Effect of naftopidil on nocturia after failure of tamsulosin.
Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Drug Administration Schedule; Follow-Up Studies; Humans; Male; Middle Aged; Naphthalenes; Nocturia; Piperazines; Prostatic Hyperplasia; Quality of Life; Retreatment; Sulfonamides; Tamsulosin; Treatment Failure | 2008 |
α(1)-adrenoceptor blocker naftopidil improves sleep disturbance with reduction in nocturnal urine volume.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Aged, 80 and over; Humans; Male; Middle Aged; Naphthalenes; Nocturia; Piperazines; Prevalence; Quality of Life; Sleep Wake Disorders; Surveys and Questionnaires; Treatment Outcome | 2011 |
4 other study(ies) available for naftopidil and Nycturia
| Article | Year |
|---|---|
Usefulness of naftopidil for dysuria in benign prostatic hyperplasia and its optimal dose--comparison between 75 and 50 mg.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Compliance; Dose-Response Relationship, Drug; Drug Administration Schedule; Dysuria; Humans; Male; Naphthalenes; Nocturia; Piperazines; Prostatic Hyperplasia; Treatment Outcome; Urinary Bladder; Urinary Bladder, Overactive; Urodynamics | 2009 |
[Efficacy of naftopidil for nocturia and consequent sleep disturbance in patients with benign prostatic hyperplasia].
Topics: Administration, Oral; Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Humans; Male; Middle Aged; Naphthalenes; Nocturia; Piperazines; Prostatic Hyperplasia; Quality of Life; Sleep Wake Disorders; Treatment Outcome | 2010 |
[Additional effect of propiverine for naftopidil-resistant nocturia in the patient with benign prostate hypertrophy].
Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Benzilates; Cholinergic Antagonists; Drug Resistance; Drug Therapy, Combination; Humans; Male; Middle Aged; Naphthalenes; Nocturia; Piperazines; Prospective Studies; Prostatic Hyperplasia | 2011 |
[The effectiveness of naftopidil in patients with benign prostatic hyperplasia evaluated by QOL index].
Topics: Adrenergic alpha-Antagonists; Aged; Drug Administration Schedule; Humans; Male; Middle Aged; Naphthalenes; Nocturia; Piperazines; Prostatic Hyperplasia; Quality of Life; Urination Disorders; Urodynamics | 2007 |